Home » Stocks » SWAV

ShockWave Medical, Inc. (SWAV)

Stock Price: $144.89 USD -3.57 (-2.40%)
Updated May 6, 2021 4:00 PM EDT - Market closed
Market Cap 5.19B
Revenue (ttm) 67.79M
Net Income (ttm) -65.70M
Shares Out 33.09M
EPS (ttm) -1.99
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day May 6
Last Price $144.89
Previous Close $148.46
Change ($) -3.57
Change (%) -2.40%
Day's Open 147.14
Day's Range 138.21 - 150.94
Day's Volume 383,673
52-Week Range 37.76 - 169.00

News

Hide News
  • All
  • Videos
  • Press Releases
  • Conversation

New Technology Add-on Payment (NTAP) Included in Proposed Fiscal Year 2022 Rule New Technology Add-on Payment (NTAP) Included in Proposed Fiscal Year 2022 Rule

1 week ago - GlobeNewsWire

SANTA CLARA, Calif., April 27, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular...

1 week ago - GlobeNewsWire

SANTA CLARA, Calif., April 12, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex cal...

3 weeks ago - GlobeNewsWire

Which of these amazing medical technology companies is better for your portfolio for the next decade?

Other stocks mentioned: BFLY
4 weeks ago - The Motley Fool

The company announced preliminary first-quarter results.

1 month ago - The Motley Fool

Announces Preliminary Revenue Range for the First Quarter of 2021 Announces Preliminary Revenue Range for the First Quarter of 2021

1 month ago - GlobeNewsWire

Buying these stocks is a smart way to make that stimulus check work for your future.

Other stocks mentioned: FINV, JMIA
1 month ago - The Motley Fool

The medical-device maker needs to keep its foot on the revenue gas.

2 months ago - The Motley Fool

And investors have lots to like.

2 months ago - The Motley Fool

Hint: Focus on the business, not the stock.

Other stocks mentioned: TSLA, TWLO
2 months ago - The Motley Fool

Shockwave Medical (SWAV) delivered earnings and revenue surprises of -12.20% and 11.60%, respectively, for the quarter ended December 2020. Do the numbers hold clues to what lies ahead for the stock?

2 months ago - Zacks Investment Research

Shares of ShockWave Medical (NASDAQ:SWAV) were unchanged in after-market trading after the company reported Q4 results. Quarterly Results Earnings per share increased 6.12% year over year to ($0.46), wh...

2 months ago - Benzinga

SANTA CLARA, Calif., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calc...

2 months ago - GlobeNewsWire

Shockwave Medical (SWAV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

2 months ago - Zacks Investment Research

SANTA CLARA, Calif., Jan. 19, 2021 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calc...

3 months ago - GlobeNewsWire

No news is good news for this company.

3 months ago - The Motley Fool

No news was good news for the medical device maker.

4 months ago - The Motley Fool

With so much hype baked into the market, smart speculators may want to consider these under-the-radar breakout stocks for 2021. The post 7 Under-the-Radar Breakout Stocks for 2021 appeared first on Inve...

Other stocks mentioned: CRLBF, FRCOY, FRPT, PCRFY, PRTS, SE
4 months ago - InvestorPlace

Four New C-Codes for IVL Performed Below the Knee in Hospital Outpatient Setting Four New C-Codes for IVL Performed Below the Knee in Hospital Outpatient Setting

5 months ago - GlobeNewsWire

Smid-cap MedTech company ShockWave Medical Inc (NASDAQ: SWAV) has seen its shares appreciate over 120% year-to-date. The ShockWave Analyst: BofA Securities analyst Bob Hopkins downgraded ShockWave from ...

5 months ago - Benzinga

SANTA CLARA, Calif., Nov. 18, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular d...

5 months ago - GlobeNewsWire

ShockWave has key differentiators that look set to make a remedial breakthrough in peripheral vascular interventions. The CAD III and PAD III IVL studies have shown superior efficacy and safety results ...

5 months ago - Seeking Alpha

Shockwave Medical, Inc. (SWAV) CEO Douglas Godshall on Q3 2020 Results - Earnings Call Transcript

5 months ago - Seeking Alpha

Shockwave Medical (SWAV) delivered earnings and revenue surprises of 30.91% and 34.87%, respectively, for the quarter ended September 2020. Do the numbers hold clues to what lies ahead for the stock?

5 months ago - Zacks Investment Research

Shares of ShockWave Medical (NASDAQ:SWAV) were flat in after-market trading after the company reported Q3 results. Quarterly Results Earnings per share were up 17.39% year over year to ($0.38), which be...

5 months ago - Benzinga

SANTA CLARA, Calif., Nov. 09, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calc...

5 months ago - GlobeNewsWire

Disrupt PAD III is Largest Randomized Study of Complex Patients Typically Excluded from Clinical Trials Disrupt PAD III is Largest Randomized Study of Complex Patients Typically Excluded from Clinical T...

5 months ago - GlobeNewsWire

Shockwave Medical (SWAV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

6 months ago - Zacks Investment Research

SANTA CLARA, Calif., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex calc...

6 months ago - GlobeNewsWire

SANTA CLARA, Calif., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat severely cal...

6 months ago - GlobeNewsWire

You won't see many headlines about these stocks. But they're well positioned to deliver big gains.

Other stocks mentioned: CRLBF, DG
6 months ago - The Motley Fool

Positive Disrupt CAD III Data Submitted to FDA in Premarket Approval Application Positive Disrupt CAD III Data Submitted to FDA in Premarket Approval Application

6 months ago - GlobeNewsWire

SANTA CLARA, Calif., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat severely cal...

7 months ago - GlobeNewsWire

SANTA CLARA, Calif., Aug. 26, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular...

8 months ago - GlobeNewsWire

ShockWave Medical's (SWAV) CEO Doug Godshall on Q2 2020 Results - Earnings Call Transcript

8 months ago - Seeking Alpha

Shares of ShockWave Medical (NASDAQ:SWAV) moved higher by 1.5% in after-market trading after the company reported Q2 results.

8 months ago - Benzinga

Shockwave Medical (SWAV) delivered earnings and revenue surprises of 15.15% and 6.04%, respectively, for the quarter ended June 2020. Do the numbers hold clues to what lies ahead for the stock?

8 months ago - Zacks Investment Research

SANTA CLARA, Calif., Aug. 11, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex ca...

8 months ago - GlobeNewsWire

Shockwave Medical (SWAV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

9 months ago - Zacks Investment Research

SANTA CLARA, Calif., July 30, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular...

9 months ago - GlobeNewsWire

SANTA CLARA, Calif., July 21, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (Nasdaq: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat complex ca...

9 months ago - GlobeNewsWire

SANTA CLARA, Calif., July 20, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular...

9 months ago - GlobeNewsWire

The company isn't taking the ruling lying down.

9 months ago - The Motley Fool

SANTA CLARA, Calif., July 08, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat complex calcified cardiovascular...

9 months ago - GlobeNewsWire

Catalysts are potentially on the way for these leading medical device stocks.

Other stocks mentioned: ABT, ISRG
10 months ago - The Motley Fool

SANTA CLARA, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (“Shockwave”) (Nasdaq: SWAV) today announced the pricing of its public offering of 1,700,000 shares of its common stock a...

10 months ago - GlobeNewsWire

SANTA CLARA, Calif., June 16, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (“Shockwave”) (Nasdaq: SWAV) today announced it has commenced an underwritten public offering of 1,700,000 shares of its ...

10 months ago - GlobeNewsWire

Centers for Medicare & Medicaid Services Issues New Codes for Peripheral Intravascular Lithotripsy Performed in Hospital Outpatient and Inpatient Settings Centers for Medicare & Medicaid Services Issues...

10 months ago - GlobeNewsWire

ShockWave Medical, Inc. (SWAV) CEO Doug Godshall on Q1 2020 Results - Earnings Call Transcript

11 months ago - Seeking Alpha

Shockwave Medical (SWAV) delivered earnings and revenue surprises of -22.92% and 20.52%, respectively, for the quarter ended March 2020. Do the numbers hold clues to what lies ahead for the stock?

11 months ago - Zacks Investment Research

About SWAV

ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology to treat calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease; C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee peripheral artery disease. It serves interventional cardiologists, vascular surgeons, and interventional radiologists ... [Read more...]

Industry
Medical Devices
IPO Date
Mar 7, 2019
CEO
Douglas Godshall
Employees
449
Stock Exchange
NASDAQ
Ticker Symbol
SWAV
Full Company Profile

Financial Performance

In 2020, SWAV's revenue was $67.79 million, an increase of 57.92% compared to the previous year's $42.93 million. Losses were -$65.70 million, 28.5% more than in 2019.

Financial Statements

Analyst Forecasts

According to 6 analysts, the average rating for SWAV stock is "Buy." The 12-month stock price forecast is 151.80, which is an increase of 4.77% from the latest price.

Price Target
$151.80
(4.77% upside)
Analyst Consensus: Buy